Scientists at Ghent University explore bacterial effects on digestive
health
COPPELL, Texas--(BUSINESS WIRE)--Oct. 10, 2012--
Mannatech,
Incorporated (NASDAQ: MTEX),
the leading innovator and provider of naturally sourced supplements
based on Real
Food Technology® solutions, announced today the
publication of a study that employed state-of-the-art technology to
further explore the prebiotic effects of its Ambrotose®
products. Performed by scientists at The Laboratory of Microbial Ecology
and Technology (LabMET) at Ghent University (Universiteit Gent) in
Ghent, Belgium, the study was published in the Antonie van
Leeuwenhoek Journal of Microbiology.1
“As The Economist magazine’s recent cover story, “Microbes
Maketh Man,” made clear, the bacteria that populate the human
body—particularly those in the gut—have an enormous impact on our
health,” commented Dr. Robert Sinnott, Chief Science Officer and CEO at
Mannatech, Incorporated. “LabMET scientists have been leaders in the
development of tools to better assess human gut bacterial populations.
This is the first study to apply 16sRNA genes-based pyrosequencing in a
Simulator of the Human Intestinal Microbial Ecosystem (SHIME) study.”
The pyrosequencing technique allowed LabMET scientists to explore more
deeply findings from a previous study published by Ghent University
scientists, which showed that Advanced
Ambrotose powder exhibited prebiotic effects along the entire colon.2
Scientists at LabMET are devoted to investigating the optimal management
of microbial resources, with the goal of developing novel products and
processes that can improve the environment or human health in the most
sustainable way.
To learn more about Mannatech and its Ambrotose
technologies, visit Mannatech.com.
Learn more about Mannatech science and related publications and studies
at MannatechScience.org.
Reference List
1Marzorati M, Maignien L, Verhelst A et al. Barcoded
pyrosequencing analysis of the microbial community in a simulator of the
human gastrointestinal tract showed a colon region-specific microbiota
modulation for two plant-derived polysaccharide blends. Antonie Van
Leeuwenhoek 2012. Published online October 5, 2012.
2Marzorati M, Verhelst A, Luta G et al. In vitro
modulation of the human gastrointestinal microbial community by
plant-derived polysaccharide-rich dietary supplements. Int J Food
Microbiol 2010;139:168-76.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico and Namibia. For more
information, visit Mannatech.com.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com